ezetimibe has been researched along with Cholesterol Ester Storage Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chuang, JC; Lopez, AM; Posey, KS; Turley, SD | 1 |
Hegele, RA; Liu, DM; Miskie, BA; Tadiboyina, VT; Wang, J | 1 |
2 other study(ies) available for ezetimibe and Cholesterol Ester Storage Disease
Article | Year |
---|---|
Ezetimibe markedly attenuates hepatic cholesterol accumulation and improves liver function in the lysosomal acid lipase-deficient mouse, a model for cholesteryl ester storage disease.
Topics: Animals; Azetidines; Body Weight; Cholesterol; Cholesterol Ester Storage Disease; Disease Models, Animal; Ezetimibe; Hepatomegaly; Intestinal Mucosa; Intestines; Liver; Liver Function Tests; Male; Mice; Organ Size; Rats; Sterol Esterase; Triglycerides | 2014 |
Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease.
Topics: Adolescent; Amino Acid Sequence; Azetidines; Base Sequence; Child; Child, Preschool; Cholesterol Ester Storage Disease; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Lipoproteins; Lovastatin; Male; Molecular Sequence Data; Sterol Esterase | 2005 |